 role herpes simplex virus development oral mucositis bone marrow transplant recipients Herpes simplex virus HSV major etiologic factor development ulcerative mucositis bone marrow transplant BMT recipients study patients BMTs days post-transplant ulcerative mucositis presence culturable HSV Fifty-nine patients prophylactic acyclovir Forty-six patients ulcerative lesions culture negative HSV source transplant autologous versus allogenic HSV antibody status patient frequency mucositis regimen significant factor severity ulcerative mucositis majority ulcers movable nonkeratinized mucosa BMT recipients usual sites reactivation intraoral HSV nonmovable mucosa HSV major etiologic agent mucositis BMT recipients acyclovir effective agent HSV reactivation